COVID 19 infection: Pediatric perspectives

COVID 19 infection: Pediatric perspectives

Abstract The coronavirus disease 2019 (COVID‐19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has rapidly spread across the globe, causing innumerable deaths and a massive economic catastrophe. Exposure to household members with confirmed COVID‐19 is the most commo...

Full description

Bibliographic Details
Main Authors:	Adebayo Adeyinka, Keneisha Bailey, Louisdon Pierre, Noah Kondamudi
Format:	Article
Language:	English
Published:	Wiley 2021-02-01
Series:	Journal of the American College of Emergency Physicians Open
Subjects:	Angiotensin‐Converting Enzyme 2 (ACE2) COVID‐19 Pediatric Multi‐System Inflammatory Syndrome (MISC) SARS‐COV‐2 steroid Vasoactive‐Inotropic Score (VIS)
Online Access:	https://doi.org/10.1002/emp2.12375

Similar Items

The Role of Glutathione in Protecting against the Severe Inflammatory Response Triggered by COVID-19
by: Francesca Silvagno, et al.
Published: (2020-07-01)

Neuropsychiatric Disorders and COVID-19: What We Know So Far
by: Fernanda Majolo, et al.
Published: (2021-09-01)

ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues
by: Sally Badawi, et al.
Published: (2021-01-01)

Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock?
by: Karim Bendjelid
Published: (2020-07-01)

Angiotensin-converting enzyme 2. Approaches to pathogenetic therapy of COVID-19
by: Polina O. Shatunova, et al.
Published: (2020-09-01)

Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients
by: Ikram Omar Osman, et al.
Published: (2021-06-01)

Clinical Profile of COVID-19 in Children and Research Progress on Angiotensin-converting Enzyme 2: A Mini-review
by: Qian Gao, et al.
Published: (2020-10-01)

COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice
by: Cathleen Lutz, et al.
Published: (2020-06-01)

Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and Non-human Primates
by: Shuyu Shou, et al.
Published: (2021-08-01)

Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-Cov-2 Infection In Vitro
by: Dean Gilham, et al.
Published: (2021-04-01)

Acute upper extremity ischemia and symptomatic popliteal artery aneurysm secondary to coronavirus disease 2019
by: Karthikeshwar Kasirajan, MD
Published: (2021-06-01)

Neuropathologists play a key role in establishing the extent of COVID-19 in human patients
by: Lokman Cevik, et al.
Published: (2020-04-01)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
by: Carlos P. Vio, et al.
Published: (2020-06-01)

The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains
by: Rongrong Chen, et al.
Published: (2021-01-01)

Male predisposition to severe COVID-19: Review of evidence and potential therapeutic prospects
by: Desmond Omane Acheampong, et al.
Published: (2020-11-01)

ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
by: Federica Saponaro, et al.
Published: (2020-09-01)

ACE2-cytomimetic particles restrict SARS-Cov-2 spike protein binding to cellular targets
by: Thomas A. Strong, et al.
Published: (2021-12-01)

New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis
by: Yuan Hou, et al.
Published: (2020-07-01)

Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system
by: Michal Herman-Edelstein, et al.
Published: (2021-04-01)

Next-Generation Sequencing Reveals the Progression of COVID-19
by: Xiaomin Chen, et al.
Published: (2021-03-01)

A novel corona virus 2019 (COVID-19) outbreak: review article
by: Fateme Saljoughi, et al.
Published: (2021-02-01)

Severe food restriction activates the central renin angiotensin system
by: Aline Maria Arlindo De Souza, et al.
Published: (2020-01-01)

Application of System Biology to Explore the Association of Neprilysin, Angiotensin-Converting Enzyme 2 (ACE2), and Carbonic Anhydrase (CA) in Pathogenesis of SARS-CoV-2
by: Reza Zolfaghari Emameh, et al.
Published: (2020-06-01)

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies
by: Gábor Kriszta, et al.
Published: (2021-03-01)

Angiotensin-Converting Enzyme 2 (ACE2) as a Potential Diagnostic and Prognostic Biomarker for Chronic Inflammatory Lung Diseases
by: Dejan Marčetić, et al.
Published: (2021-07-01)

Case Report: Use of Anakinra in Multisystem Inflammatory Syndrome During COVID-19 Pandemic
by: Sara Della Paolera, et al.
Published: (2021-02-01)

The Use of ACE inhibitor/ARB in SARS-CoV-2 Patients: A Comprehensive Narrative Review
by: Timotius Ivan Hariyanto, et al.
Published: (2020-11-01)

Smoking and SARS-CoV-2 Disease (COVID-19): Dangerous Liaisons or Confusing Relationships?
by: Giovanni Li Volti, et al.
Published: (2020-05-01)

Mechanisms of COVID-19 Entry into the Cell: Potential Therapeutic Approaches Based on Virus Entry Inhibition in COVID-19 Patients with Underlying Diseases
by: Hadis Musavi, et al.
Published: (2021-02-01)

Debatable points of using angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in patients with COVID-19
by: O. M. Drapkina, et al.
Published: (2020-07-01)

Dysregulation of the Renin-Angiotensin-Aldosterone System (RAA) in Patients Infected with SARS-CoV-2-Possible Clinical Consequences
by: Agnieszka Dettlaff-Pokora, et al.
Published: (2021-04-01)

Renin-angiotensin-aldosterone system inhibitors – a realm of confusion in COVID-19
by: Angela Madalina Lazar
Published: (2021-07-01)

ACE2 as a Therapeutic Target for COVID-19; its Role in Infectious Processes and Regulation by Modulators of the RAAS System
by: Veronique Michaud, et al.
Published: (2020-07-01)

Predicting the Animal Susceptibility and Therapeutic Drugs to SARS-CoV-2 Based on Spike Glycoprotein Combined With ACE2
by: Min Shen, et al.
Published: (2020-10-01)

ACE2 and Furin Expressions in Oral Epithelial Cells Possibly Facilitate COVID-19 Infection via Respiratory and Fecal–Oral Routes
by: Mei Zhong, et al.
Published: (2020-12-01)

Macrolides and COVID-19: An optimum premise
by: Hayder M Al-Kuraishy, et al.
Published: (2020-01-01)

Bradykinin as a Probable Aspect in SARS-Cov-2 Scenarios: Is Bradykinin Sneaking out of Our Sight?
by: Seyed-Mohammad Ghahestani, et al.
Published: (2020-05-01)

SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis
by: Jincheng Xu, et al.
Published: (2020-07-01)

Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19
by: Tatsuya Maruhashi, et al.
Published: (2021-05-01)

Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
by: Enrique Ambrocio-Ortiz, et al.
Published: (2021-08-01)